Regeneron Pharmaceuticals
REGN
REGN
1,075 hedge funds and large institutions have $56.6B invested in Regeneron Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 175 funds opening new positions, 426 increasing their positions, 319 reducing their positions, and 97 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.67% less ownership
Funds ownership: 85.94% → 85.27% (-0.67%)
12% less funds holding in top 10
Funds holding in top 10: 17 → 15 (-2)
33% less call options, than puts
Call options by funds: $985M | Put options by funds: $1.48B
Holders
1,075
Holding in Top 10
15
Calls
$985M
Puts
$1.48B
Top Buyers
| 1 | +$309M | |
| 2 | +$245M | |
| 3 | +$201M | |
| 4 |
Dodge & Cox
San Francisco,
California
|
+$176M |
| 5 |
BlackRock
New York
|
+$154M |
Top Sellers
| 1 | -$635M | |
| 2 | -$547M | |
| 3 | -$224M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$167M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$147M |